Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023


Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction ("PCR")-based technologies, today announced that it will release financial results for the three months ended December 31, 2022, after the market closes on Thursday, February 9, 2023. The Company will host a conference call for the investment community to discuss its results and answer questions at 4:30 p.m. ET.

Date & Time: Thursday, February 9 @ 4:30 p.m. ET

Dial In (ask to be joined into the Applied DNA Sciences call):

A telephonic replay of the conference call will be available for 1 week following the conclusion of the live call:

An archived webcast replay of the conference call will be available for 1 year following the conclusion of the live call: https://event.choruscall.com/mediaframe/webcast.html?webcastid=gZ93PCbr

An accompanying slide presentation will be embedded in the webcast (live and replay) and can also be accessed in the ?Company Events' section of the ?News & Events' tab of the Applied DNA investor relations website at https://investors.adnas.com/.

About Applied DNA Sciences

Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in three primary business markets: (i) the manufacture of DNA for use in nucleic acid-based therapeutics; (ii) the detection of DNA in molecular diagnostics testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company's common stock is listed on NASDAQ under the ticker symbol 'APDN,' and its publicly traded warrants are listed on OTC under the ticker symbol 'APPDW.'


These press releases may also interest you

at 07:45
HEALWELL AI achieved annual revenue from continuing operations of $7.32 million in fiscal 2023. HEALWELL ended 2023 with a strong balance sheet, having secured approximately $29.5 million from convertible debt and equity financings.Since its relaunch...

at 07:45
Magaya, the leading provider of logistics and supply chain automation software, is committing an additional multimillion-dollar...

at 07:35
Ironwood Pharmaceuticals, Inc. , a GI-focused healthcare company, today announced positive, primary results up to Day 91 for its Phase II exploratory STARGAZE trial evaluating apraglutide in patients with steroid-refractory gastrointestinal acute...

at 07:35
The Real Brokerage Inc. , the fastest-growing, publicly traded brokerage, today announced that the Jon Campbell Team, formerly known as the Don Wenner Team, has joined the company. The team ranked as RealTrends' No. 1 Mega team in Pennsylvania and...

at 07:35
On March 21, xFusion Technologies International Co., Ltd. successfully hosted its Tech Summit 2024 and Partner Conference in Hong Kong. The conference focused on sharing industry trends and xFusion's product strategies centered around AI and green...

at 07:35
dentalcorp Holdings Ltd. ("dentalcorp" or the "Company") , Canada's largest and one of North America's fastest growing networks of dental practices, today announced that it will present at the following investor conferences: 2024 Bloom Burton & Co....



News published on and distributed by: